These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11837487)

  • 1. Serum insulin assay.
    Jauhari J; Jauhari S; Jauhari A
    J Assoc Physicians India; 2001 Aug; 49():858. PubMed ID: 11837487
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment and preliminary clinical application of radioreceptor assay for the determination of insulin in human sera.
    Zhu JH; Feng YM; Wang HY; Xu JM
    Chin Med J (Engl); 1984 Nov; 97(11):865-70. PubMed ID: 6443281
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus.
    Nishimura F; Kono T; Fujimoto C; Iwamoto Y; Murayama Y
    J Int Acad Periodontol; 2000 Apr; 2(2):49-55. PubMed ID: 12666961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.
    Flores-Martínez SE; Islas-Andrade S; Machorro-Lazo MV; Revilla MC; Juárez RE; Mújica-López KI; Morán-Moguel MC; López-Cardona MG; Sánchez-Corona J
    Ann Genet; 2004; 47(4):339-48. PubMed ID: 15581831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes.
    Cucuianu M; Nistor T; Hâncu N; Orbai P; Muscurel C; Stoian I
    Rom J Intern Med; 2002; 40(1-4):43-51. PubMed ID: 15526539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.
    Ezenwaka CE; Kalloo R; Uhlig M; Eckel J
    Horm Metab Res; 2004 Apr; 36(4):238-42. PubMed ID: 15114523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
    Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
    Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin secretion and aging. Implications for insulin therapy in the geriatric patient with diabetes mellitus].
    Fritsche A; Stumvoll M; Häring HU
    Med Klin (Munich); 2003 Apr; 98(5):287-91. PubMed ID: 12721675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reference value and cut-off value for diagnosis of insulin resistance in type 2 diabetes mellitus].
    Kuwana B; Urayama O; Kawai K
    Rinsho Byori; 2002 Apr; 50(4):398-403. PubMed ID: 12014020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, insulin, and risk of cancer.
    Schiel R; Beltschikow W; Steiner T; Stein G
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.
    Lewitt MS; Hall K; Bang P; Brismar K
    Metabolism; 2005 Mar; 54(3):275-80. PubMed ID: 15736102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.
    Fujinami A; Ohta K; Obayashi H; Fukui M; Hasegawa G; Nakamura N; Kozai H; Imai S; Ohta M
    Clin Biochem; 2008 Jul; 41(10-11):812-7. PubMed ID: 18402781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study.
    Li D; Xu T; Takase H; Tokimitsu I; Zhang P; Wang Q; Yu X; Zhang A
    Clin Nutr; 2008 Apr; 27(2):203-11. PubMed ID: 18314230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analog insulin preparations in patients with type 2 diabetes. Better rapid and brief than sluggish and long].
    MMW Fortschr Med; 2005 Nov; 147(46):60. PubMed ID: 16358638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.